These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7942286

  • 1. Targeted and non-targeted actions of anti-cancer drugs.
    Weber G, Prajda N.
    Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
    [Abstract] [Full Text] [Related]

  • 2. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N, Natsumeda Y, Ikegami T, Reardon MA, Szondy S, Hashimoto Y, Emrani J, Weber G.
    Biochem Pharmacol; 1988 Mar 01; 37(5):875-80. PubMed ID: 3345200
    [Abstract] [Full Text] [Related]

  • 3. Regulation of de novo and salvage pathways in chemotherapy.
    Weber G, Nagai M, Natsumeda Y, Ichikawa S, Nakamura H, Eble JN, Jayaram HN, Zhen WN, Paulik E, Hoffman R.
    Adv Enzyme Regul; 1991 Mar 01; 31():45-67. PubMed ID: 1877399
    [Abstract] [Full Text] [Related]

  • 4. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N, Hata Y, Abonyi M, Singhal RL, Weber G.
    Cancer Res; 1993 Dec 15; 53(24):5982-6. PubMed ID: 7903199
    [Abstract] [Full Text] [Related]

  • 5. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G, Lui MS, Natsumeda Y, Faderan MA.
    Adv Enzyme Regul; 1983 Dec 15; 21():53-69. PubMed ID: 6443595
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate decreases thymidine kinase activity.
    Abonyi M, Prajda N, Hata Y, Nakamura H, Weber G.
    Biochem Biophys Res Commun; 1992 Aug 31; 187(1):522-8. PubMed ID: 1520343
    [Abstract] [Full Text] [Related]

  • 7. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G, Natsumeda Y, Lui MS, Faderan MA, Liepnieks JJ, Elliott WL.
    Adv Enzyme Regul; 1984 Aug 31; 22():69-93. PubMed ID: 6206692
    [Abstract] [Full Text] [Related]

  • 8. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y, Ikegami T, Olah E, Weber G.
    Cancer Res; 1989 Jan 01; 49(1):88-92. PubMed ID: 2461800
    [Abstract] [Full Text] [Related]

  • 9. Antimetabolites reduce the activities of enzymes with short half-lives in addition to inhibiting their specific targets.
    Weber G, Prajda N, Singhal RL.
    Adv Exp Med Biol; 1994 Jan 01; 370():145-50. PubMed ID: 7660878
    [No Abstract] [Full Text] [Related]

  • 10. Tiazofurin: molecular and clinical action.
    Weber G, Prajda N, Abonyi M, Look KY, Tricot G.
    Anticancer Res; 1996 Jan 01; 16(6A):3313-22. PubMed ID: 9042306
    [Abstract] [Full Text] [Related]

  • 11. Role of differentiation induction in action of purine antimetabolites.
    Weber G, Hata Y, Prajda N.
    Pharm World Sci; 1994 Apr 15; 16(2):77-83. PubMed ID: 8032345
    [Abstract] [Full Text] [Related]

  • 12. Regulation of GTP biosynthesis.
    Weber G, Nakamura H, Natsumeda Y, Szekeres T, Nagai M.
    Adv Enzyme Regul; 1992 Apr 15; 32():57-69. PubMed ID: 1353938
    [Abstract] [Full Text] [Related]

  • 13. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW, Jayaram HN, Cooney DA.
    Adv Enzyme Regul; 1982 Apr 15; 20():57-73. PubMed ID: 7113804
    [Abstract] [Full Text] [Related]

  • 14. Salvage pathways as targets of chemotherapy.
    Weber G, Jayaram HN, Pillwein K, Natsumeda Y, Reardon MA, Zhen YS.
    Adv Enzyme Regul; 1987 Apr 15; 26():335-52. PubMed ID: 3673709
    [Abstract] [Full Text] [Related]

  • 15. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R, Ashihara H.
    Planta; 2002 Sep 15; 215(5):821-8. PubMed ID: 12244448
    [Abstract] [Full Text] [Related]

  • 16. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G, Prajda N, Lui MS, Denton JE, Aoki T, Sebolt J, Zhen YS, Burt ME, Faderan MA, Reardon MA.
    Adv Enzyme Regul; 1982 Sep 15; 20():75-96. PubMed ID: 6180609
    [Abstract] [Full Text] [Related]

  • 17. Targets and markers of selective action of tiazofurin.
    Weber G, Natsumeda Y, Pillwein K.
    Adv Enzyme Regul; 1985 Sep 15; 24():45-65. PubMed ID: 2424286
    [Abstract] [Full Text] [Related]

  • 18. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum.
    Reyes P, Rathod PK, Sanchez DJ, Mrema JE, Rieckmann KH, Heidrich HG.
    Mol Biochem Parasitol; 1982 May 15; 5(5):275-90. PubMed ID: 6285190
    [Abstract] [Full Text] [Related]

  • 19. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G, Nagai M, Prajda N, Nakamura H, Szekeres T, Olah E.
    Cancer Commun; 1991 Apr 15; 3(4):127-32. PubMed ID: 2025497
    [Abstract] [Full Text] [Related]

  • 20. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS, Taniki T, Weber G.
    Oncol Res; 1992 Apr 15; 4(2):73-8. PubMed ID: 1596584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.